Get started
Author

Ugo Orfanelli

Observed names: Orfanelli, Ugo, U Orfanelli, U. Orfanelli
ORCID: 0000-0003-3792-9174
Observed ORCID: 0000-0003-3792-9174
OpenAlex ID: A5015510456
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 · Rossella Galli, Elena Binda, et al. · Cancer Research · 2,614
PDF
Plasma cells require autophagy for sustainable immunoglobulin production
2013 · Niccolò Pengo, Maria Scolari, et al. · Nature Immunology · 435
Identification of novel sense and antisense transcription at the TRPM2 locus in cancer
2008 · Ugo Orfanelli, Ann-Kathrin Wenke, et al. · Cell Research · 118
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells
2015 · Enrico Milan, Tommaso Perini, et al. · Autophagy · 116
PDF
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity
2017 · Laura Oliva, Ugo Orfanelli, et al. · Blood · 92
PDF
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer
2014 · U Orfanelli, E Jachetti, et al. · Oncogene · 85
The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis
2020 · Chiara Fucci, Massimo Resnati, et al. · Cell Reports · 50
PDF
Identification of a New EGF-Repeat-Containing Gene from Human Xp22: A Candidate for Developmental Disorders
2000 · Georg Buchner, Ugo Orfanelli, et al. · Genomics · 31
Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease
2020 · Daniela Merlotti, Maria Materozzi, et al. · The Journal of Clinical Endocrinology & Metabolism · 25
PDF
Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation
2018 · R. Alessia Battista, Massimo Resnati, et al. · PLoS ONE · 23
PDF
MHC Class II Transactivator Is an In Vivo Regulator of Osteoclast Differentiation and Bone Homeostasis Co-opted From Adaptive Immunity
2013 · Elisa Benasciutti, Elisabetta Mariani, et al. · Journal of Bone and Mineral Research · 23
PDF
MAEG, an EGF-repeat containing gene, is a new marker associated with dermatome specification and morphogenesis of its derivatives
2000 · Georg Buchner, Vania Broccoli, et al. · Mechanisms of Development · 23
PDF
Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells
2017 · Eleonora Fonte, Maria Giovanna Vilia, et al. · Haematologica · 15
AntiHunter 2.0: increased speed and sensitivity in searching BLAST output for EST antisense transcripts
2005 · G. Lavorgna, R. Triunfo, et al. · Nucleic Acids Research · 15
PDF
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma
2022 · Matteo Trudu, Laura Oliva, et al. · Frontiers in Oncology · 11
PDF
A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver
2024 · Maria Materozzi, Massimo Resnati, et al. · Scientific Reports · 9
PDF
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma
2025 · Tommaso Perini, Paola Zordan, et al. · Blood · 6
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma
2024 · Massimo Resnati, Sara Pennacchio, et al. · Haematologica · 4
PDF
Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related disease
2025 · Claudia Minici, Jasmin Mahajne, et al. · European Journal of Internal Medicine · 1
Targeting the Mitochondrial Protease Clpp Unveils Mitochondrial Vulnerabilities in Multiple Myeloma
2022 · Tommaso Perini, Laura Oliva, et al. · Blood · 1
The C-terminal region of TENT5 proteins drives ER-associated mRNA polyadenylation via FNDC3 interaction
2026 · Lisa Viviani, Daniel Lacidogna, et al. · Cell Reports
The Mitochondrial Protease Clpp Is a Metabolic Vulnerability and an Immunogenic Trigger Against Multiple Myeloma
2024 · Tommaso Perini, Paola Zordan, et al. · Blood
P-363 Mitochondrial protease ClpP is a novel immunogenic vulnerability in multiple myeloma
2023 · Tommaso Perini, Paola Zordan, et al. · Clinical Lymphoma Myeloma & Leukemia
P-109: ER-phagic control of lipid metabolism supports multiple myeloma cell survival
2022 · Laura Oliva, Matteo Trudu, et al. · Clinical Lymphoma Myeloma & Leukemia
P-111: Targeting the mitochondrial protease ClpP unveils novel vulnerabilities in multiple myeloma
2022 · Tommaso Perini, Maria Materozzi, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 31
Citation count: 3,697
H-index: 14
I10-index: 15
Year
Topic
Type